New combo without chemotherapy aims to shrink rectal tumors before surgery

This small study tests a new approach for people with stage II/III rectal cancer that has not spread. Instead of chemotherapy, patients receive targeted internal radiation followed by two doses of the immunotherapy drug nivolumab before surgery. The goal is to see if this combination is safe, practical, and can make the tumor disappear completely by the time of surgery.